At4g26450 Antibody

What is the At4g26450 Antibody and what organism is it designed for?

The At4g26450 Antibody (Product Code: CSB-PA317141XA01DOA) is a polyclonal antibody raised in rabbits using recombinant Arabidopsis thaliana At4g26450 protein as the immunogen. It is specifically designed to target and bind to the At4g26450 protein in Arabidopsis thaliana (Mouse-ear cress), a model organism widely used in plant molecular biology research . This antibody is purified using the antigen affinity method, making it highly specific for its target protein. It's important to note that this antibody is developed exclusively for research applications and should not be used for diagnostic or therapeutic procedures .

What are the recommended storage conditions for the At4g26450 Antibody?

For optimal antibody performance and longevity, the At4g26450 Antibody should be stored at either -20°C or -80°C immediately upon receipt . The manufacturer's specifications indicate that repeated freeze-thaw cycles should be avoided as they can compromise antibody integrity and binding affinity. The antibody is supplied in liquid form with a storage buffer composition of 50% Glycerol, 0.01M PBS at pH 7.4, and contains 0.03% Proclin 300 as a preservative . When handling the antibody, it's advisable to aliquot it into smaller volumes for single-use applications to prevent multiple freeze-thaw cycles. Always ensure proper temperature monitoring of storage facilities and follow good laboratory practices for antibody handling.

What validated applications exist for the At4g26450 Antibody?

The At4g26450 Antibody has been validated specifically for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . These techniques allow researchers to detect and quantify the presence of the target protein in various sample types. When using this antibody for Western Blot, researchers should expect to identify the specific antigen corresponding to the At4g26450 protein from Arabidopsis thaliana samples . While these are the manufacturer-validated applications, researchers might explore additional applications such as immunohistochemistry or immunofluorescence, though such applications would require extensive validation by the end-user. Each application should include appropriate positive and negative controls to ensure specificity and minimize non-specific binding artifacts.

How should researchers determine the optimal antibody concentration for experimental use?

Determining the optimal concentration of At4g26450 Antibody for experimental use requires a systematic titration approach. For Western Blot applications, start with a concentration range between 1:500 to 1:5000 dilution of the antibody stock solution. For ELISA, beginning with dilutions between 1:1000 to 1:10000 is recommended. When performing these optimizations, researchers should:

• Prepare a series of antibody dilutions within the suggested ranges

• Run identical samples with each dilution

• Evaluate signal-to-noise ratio for each concentration

• Select the dilution that provides clear specific binding with minimal background

The optimal antibody concentration will depend on multiple factors including sample type, protein abundance, and detection method. Similar methodological optimization approaches have been documented in antibody development research, such as the A4 antibody described for virus detection . Remember that antibody sensitivity may vary between different experimental setups, so optimization should be performed for each new experimental condition.

How can researchers validate the specificity of At4g26450 Antibody for their particular experimental system?

Validating antibody specificity is crucial for ensuring reliable experimental outcomes. For the At4g26450 Antibody, implement a multi-faceted validation strategy:

• Genetic Controls: Use Arabidopsis thaliana mutants lacking or overexpressing the At4g26450 gene to confirm antibody specificity. The absence of signal in knockout mutants and enhanced signal in overexpression lines would support specificity.

• Peptide Competition Assay: Pre-incubate the antibody with excess purified At4g26450 antigen before applying to samples. Specific binding should be significantly reduced or eliminated.

• Cross-Reactivity Assessment: Test the antibody against closely related proteins or tissues from other plant species to evaluate potential cross-reactivity. The antibody is raised specifically against Arabidopsis thaliana, so cross-species reactivity should be thoroughly assessed .

• Orthogonal Detection Methods: Validate results using alternative detection methods such as mass spectrometry or RNA expression analysis to corroborate protein detection patterns.

• Immunoprecipitation-Mass Spectrometry: Perform IP-MS to identify all proteins captured by the antibody, confirming that At4g26450 is the predominant target.

This systematic validation approach mirrors methodologies employed in other antibody specificity studies, such as the detailed validation of the A4 antibody for neuraminidase detection, where binding specificity was rigorously quantified through multiple complementary techniques .

What approaches can be used to optimize immunoprecipitation protocols using the At4g26450 Antibody?

Optimizing immunoprecipitation (IP) protocols with the At4g26450 Antibody requires careful consideration of multiple variables. While not specifically listed among validated applications , researchers might explore its utility in IP experiments with appropriate optimization:

• Antibody Coupling: Covalently couple the antibody to solid supports (e.g., Protein A/G beads or magnetic beads) using optimized crosslinking conditions to prevent antibody leaching during elution.

• Buffer Optimization: Test various lysis and binding buffers with different salt concentrations (150-500 mM NaCl), detergent types (Triton X-100, NP-40, CHAPS), and pH conditions (pH 6.8-8.0) to maximize specific binding while minimizing background.

• Pre-clearing Strategy: Implement sample pre-clearing with appropriate beads to reduce non-specific binding.

• Incubation Parameters: Optimize antibody-antigen interaction by testing various incubation times (2-16 hours) and temperatures (4°C vs. room temperature).

• Elution Conditions: Compare different elution strategies including low pH, high salt, competitive elution with immunogenic peptides, or direct SDS boiling.

• Crosslinking Consideration: For studying protein complexes, evaluate formaldehyde or DSP (dithiobis(succinimidyl propionate)) crosslinking prior to cell lysis.

The optimization process should be empirically determined for the specific plant tissue and experimental conditions, similar to approaches used in other antibody-antigen interaction studies, where buffer conditions significantly impacted binding efficiency .

How can researchers apply machine learning approaches to predict At4g26450 Antibody binding characteristics?

Machine learning (ML) can provide valuable insights into antibody-antigen interactions for the At4g26450 Antibody. Researchers can implement the following approaches:

• Binding Affinity Prediction: Apply computational models to predict binding affinity between At4g26450 antibody and various epitopes. Recent research shows that ML models can analyze many-to-many relationships between antibodies and antigens, which could help predict cross-reactivity with related plant proteins .

• Out-of-Distribution Prediction: Utilize specialized ML approaches to predict binding behavior in experimental conditions not represented in training data. For example, binding prediction under various salt concentrations or pH conditions that differ from standard testing protocols .

• Active Learning Implementation: Employ active learning algorithms to strategically design experiments that maximize information gain with minimal experimental effort. Research indicates this approach can reduce the number of required experiments by up to 35% compared to random experimental design .

• Epitope Mapping: Use ML-based epitope prediction tools to identify the most likely binding regions on the At4g26450 protein structure, guiding site-directed mutagenesis experiments to confirm critical binding residues.

• Cross-Reactivity Assessment: Apply ML algorithms to predict potential cross-reactivity with other Arabidopsis proteins based on structural and sequence similarities.

The implementation of these ML approaches should include appropriate validation steps and iterative refinement of models based on experimental feedback, following the methodological framework described in recent antibody-antigen binding prediction research .

What strategies can be employed to investigate potential post-translational modifications of At4g26450 using antibody-based techniques?

Investigating post-translational modifications (PTMs) of the At4g26450 protein requires specialized antibody-based approaches:

• PTM-Specific Antibody Development: Consider developing or sourcing antibodies specifically targeting common PTMs (phosphorylation, ubiquitination, acetylation, etc.) that might occur on the At4g26450 protein.

• Two-Dimensional Western Blotting: Implement 2D gel electrophoresis followed by Western blotting with the At4g26450 Antibody to separate protein isoforms with different PTMs based on charge and molecular weight shifts.

• Phosphatase/Deacetylase Treatment: Compare antibody binding to samples before and after treatment with various enzymes that remove specific PTMs to determine if modification status affects antibody recognition.

• Mass Spectrometry Integration: Use immunoprecipitation with the At4g26450 Antibody followed by mass spectrometry analysis to identify and characterize PTMs present on the captured protein.

• Stimulus-Response Experiments: Expose plant samples to various stresses or treatments known to induce specific PTMs, then compare antibody binding patterns to detect potential changes in modification status.

• Sequential Immunoprecipitation: Perform sequential IPs using first PTM-specific antibodies followed by At4g26450 Antibody (or vice versa) to enrich for modified forms of the protein.

When implementing these strategies, researchers should consider the potential impact of PTMs on epitope accessibility and antibody binding efficiency, similar to considerations in other antibody-based studies targeting proteins with variable modification states .

How can researchers implement the At4g26450 Antibody in multiplex detection systems for studying protein interaction networks?

Implementing the At4g26450 Antibody in multiplex detection systems enables simultaneous analysis of multiple proteins and their interactions:

• Antibody Labeling Strategies: Directly label the At4g26450 Antibody with distinct fluorophores, quantum dots, or other detectable tags that are spectrally separable from labels used on other antibodies in the multiplex system.

• Proximity Ligation Assay (PLA): Combine the At4g26450 Antibody with antibodies against suspected interaction partners in PLA protocols to visualize and quantify protein-protein interactions with spatial resolution in plant tissues.

• Bead-Based Multiplex Assays: Conjugate the At4g26450 Antibody to distinctly coded microbeads for use in suspension array technologies, allowing simultaneous detection of multiple proteins in a single sample.

• Sequential Elution and Reprobing: Develop protocols for sequential elution of antibodies from blots or tissues, allowing multiple rounds of detection with different antibodies including the At4g26450 Antibody.

• Co-Immunoprecipitation Network Analysis: Use the At4g26450 Antibody as the primary capture reagent in co-IP experiments followed by mass spectrometry to identify all interaction partners.

The implementation of these multiplex strategies should include appropriate controls for antibody cross-reactivity and signal spillover between detection channels. Researchers can draw methodological insights from other multiprotein detection systems, such as those developed for virus detection platforms where antibody specificity in complex backgrounds was rigorously tested .

What sample preparation techniques optimize At4g26450 protein detection in Arabidopsis tissues?

Optimizing sample preparation is critical for successful detection of At4g26450 protein:

• Tissue Selection and Harvesting: Identify tissues with highest At4g26450 expression. Consider using young, actively growing tissues as they often have higher protein content. Harvest and flash-freeze tissues immediately in liquid nitrogen to preserve protein integrity.

• Buffer Composition: Use a protein extraction buffer containing:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100 or 0.5% NP-40

  • 1 mM EDTA

  • 1 mM PMSF

  • Protease inhibitor cocktail

  • Optional: phosphatase inhibitors if phosphorylation is relevant

• Tissue Disruption: Thoroughly grind tissue in liquid nitrogen using a mortar and pestle or bead-based homogenizer to ensure complete cell disruption while maintaining low temperature.

• Protein Solubilization: For membrane-associated proteins, include stronger detergents like 0.5% sodium deoxycholate or consider a sequential extraction approach with increasingly stringent buffers.

• Clearing Protocol: Centrifuge lysates at high speed (≥14,000 × g) for 15-20 minutes at 4°C to remove insoluble debris.

• Protein Concentration: Determine protein concentration using methods compatible with your extraction buffer (e.g., BCA assay with appropriate modifications for detergent presence).

• Sample Storage: Store aliquoted protein samples at -80°C to prevent degradation, avoiding repeated freeze-thaw cycles.

This approach incorporates plant-specific considerations while drawing on established protein extraction methodologies referenced in studies of protein isolation from Arabidopsis tissues .

What troubleshooting strategies should researchers employ when facing weak or non-specific signal issues?

When facing detection challenges with the At4g26450 Antibody, implement this systematic troubleshooting approach:

This troubleshooting matrix represents a systematic approach to resolving common detection issues, incorporating methodological considerations similar to those employed in antibody validation studies where signal specificity was rigorously evaluated through multiple complementary approaches .

How can the At4g26450 Antibody be effectively used in quantitative proteomics workflows?

Integrating the At4g26450 Antibody into quantitative proteomics workflows requires careful methodological considerations:

• Antibody-Based Enrichment: Use the At4g26450 Antibody for immunoaffinity enrichment prior to mass spectrometry analysis:

  • Conjugate antibody to solid supports (magnetic beads, agarose)

  • Perform IP under native or denaturing conditions depending on research goals

  • Include appropriate controls (IgG control, input samples)

• Quantitative Western Blot Analysis:

  • Establish a standard curve using recombinant At4g26450 protein at known concentrations

  • Ensure linearity of detection across expected concentration range

  • Use internal loading controls for normalization

  • Implement digital image analysis with appropriate software

• Multiplexed Detection Systems:

  • Label the At4g26450 Antibody for use in multiplexed assays with other target proteins

  • Ensure no spectral overlap between different detection channels

  • Include appropriate controls for each target

• Selected Reaction Monitoring (SRM) Integration:

  • Use antibody-enriched samples for targeted MS approaches

  • Identify optimal peptide transitions for At4g26450 quantification

  • Incorporate isotopically labeled standards for absolute quantification

• Spatial Proteomics Applications:

  • Apply the antibody in tissue sections for laser capture microdissection

  • Use for cell sorting based on At4g26450 expression

  • Combine with subcellular fractionation to determine protein localization

These methodological approaches enable precise quantification of At4g26450 protein across various experimental conditions, similar to quantitative proteomics strategies employed in other studies where antibody specificity and quantitative accuracy were carefully validated .

How might the At4g26450 Antibody be employed in studying plant stress responses?

The At4g26450 Antibody can be strategically employed to investigate plant stress responses through several research approaches:

• Temporal Expression Profiling: Monitor At4g26450 protein levels across different time points after exposure to various stresses (drought, salinity, temperature extremes, pathogen infection) using quantitative Western blot analysis with the antibody. This approach can reveal if At4g26450 is stress-responsive and identify the timing of maximum response.

• Tissue-Specific Responses: Combine immunohistochemistry using the At4g26450 Antibody with microscopy to map tissue-specific protein expression changes during stress conditions, potentially identifying tissues where the protein plays crucial roles during stress adaptation.

• Protein-Protein Interaction Dynamics: Use the antibody in co-immunoprecipitation experiments before and after stress exposure to identify stress-induced changes in the At4g26450 protein interaction network, potentially revealing mechanisms of stress signal transduction.

• Post-Translational Modification Analysis: Apply the antibody to enrich At4g26450 protein from stressed and non-stressed plants, followed by mass spectrometry analysis to identify stress-induced PTMs that might regulate protein function.

• Genetic Variation Studies: Compare At4g26450 protein levels across different Arabidopsis accessions under identical stress conditions to identify natural variation in protein abundance that might correlate with stress tolerance.

These approaches leverage antibody-based detection methods similar to those employed in other protein expression studies, providing valuable insights into the molecular mechanisms of plant stress responses .

What role could the At4g26450 Antibody play in advancing research on plant signaling pathways?

The At4g26450 Antibody can significantly advance plant signaling research through these specialized applications:

• Signaling Complex Identification: Use the antibody in native immunoprecipitation experiments to capture intact signaling complexes containing the At4g26450 protein, followed by mass spectrometry to identify all components of the signalosome.

• Receptor-Ligand Interaction Studies: If At4g26450 functions in receptor-mediated signaling, the antibody can be used to monitor receptor conformational changes or complex formation upon ligand binding through techniques like FRET or BRET when combined with appropriate labeling strategies.

• Phosphorylation Cascade Analysis: Combine the At4g26450 Antibody with phospho-specific antibodies in sequential immunoprecipitation experiments to map phosphorylation events within signaling cascades involving this protein.

• Subcellular Translocation Monitoring: Use immunofluorescence with the antibody to track potential redistribution of At4g26450 protein between cellular compartments during signal transduction, providing insights into spatial regulation of signaling.

• Chromatin Immunoprecipitation (ChIP): If At4g26450 is involved in transcriptional regulation, the antibody could be employed in ChIP experiments to identify genomic binding sites and target genes.

• Hormone Response Profiling: Monitor At4g26450 protein levels, modifications, or interactions in response to various plant hormones to position the protein within hormone signaling networks.

These methodological approaches to signaling research utilize antibody specificity to reveal dynamic protein behaviors, similar to approaches used in other signal transduction studies where specific antibodies were crucial for tracking protein behavior during signaling events .

How can researchers design experiments to study the functional relationship between At4g26450 and other Arabidopsis proteins?

Designing experiments to elucidate functional relationships between At4g26450 and other proteins requires a multi-faceted approach:

• Co-Immunoprecipitation Network Mapping:

  • Use the At4g26450 Antibody as bait to capture interacting proteins

  • Perform reverse co-IP with antibodies against suspected partners

  • Apply quantitative proteomics to rank interaction strength

  • Include appropriate controls (IgG, competing peptides)

• Proximity-Based Interaction Studies:

  • Implement BioID or APEX2 proximity labeling with At4g26450 as the bait

  • Use the antibody to validate proximity labeling results by co-localization

  • Apply split protein complementation assays (BiFC, split-luciferase) for direct interaction testing

• Genetic Interaction Analysis:

  • Combine At4g26450 mutations with mutations in suspected partner genes

  • Use the antibody to monitor protein levels in various genetic backgrounds

  • Assess epistatic relationships through phenotypic and molecular analyses

• Comparative Expression Profiling:

  • Monitor At4g26450 and partner protein levels across tissues/conditions

  • Identify correlated expression patterns suggesting functional relationships

  • Use the antibody in multiplexed detection systems for simultaneous monitoring

• Structure-Function Relationship Studies:

  • Generate domain deletion/mutation variants of At4g26450

  • Use the antibody to assess how modifications affect protein interactions

  • Map binding domains through interaction with recombinant protein fragments

These experimental approaches incorporate methodological considerations similar to those employed in protein interaction studies where antibody specificity was essential for accurately mapping interaction networks .

What are the key considerations for reporting At4g26450 Antibody usage in scientific publications?

When reporting At4g26450 Antibody usage in scientific publications, researchers should provide comprehensive details to ensure reproducibility and transparency:

• Antibody Identification: Include complete antibody identification information:

  • Full product code (CSB-PA317141XA01DOA)

  • Manufacturer/supplier (Cusabio)

  • Host species (Rabbit)

  • Clonality (Polyclonal)

  • Immunogen details (Recombinant Arabidopsis thaliana At4g26450 protein)

• Validation Methods: Describe all validation experiments performed:

  • Specificity tests (Western blot results showing expected band size)

  • Controls used (positive, negative, peptide competition)

  • Cross-reactivity assessments with related proteins

  • Validation in relevant knockout/knockdown lines if available

• Experimental Conditions: Detail the exact experimental procedures:

  • Working concentration/dilution used

  • Incubation conditions (time, temperature, buffer composition)

  • Detection method (fluorescence, chemiluminescence, colorimetric)

  • Sample preparation methods

• Reproducibility Information: Provide data on reproducibility:

  • Antibody lot number used

  • Number of experimental replicates

  • Observed variability between experiments

  • Any deviations from manufacturer recommendations

• Data Presentation: Include representative images showing:

  • Full blots/images with molecular weight markers

  • Both positive and negative controls

  • Raw data alongside quantified results

These reporting standards align with best practices in antibody research, ensuring that other researchers can accurately evaluate and reproduce the experimental findings, similar to the detailed methodological reporting in other antibody development studies .